NOTO
gene geneOn this page
Summary
NOTO (notochord homeobox, HGNC:31839) is a protein-coding gene on chromosome 2p13.2, encoding Homeobox protein notochord (A8MTQ0). Transcription regulator acting downstream of both FOXA2 and Brachyury (T) during notochord development.
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in brain development; neuron differentiation; and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including embryonic organ development; motile cilium assembly; and regulation of cilium assembly. Predicted to be located in chromatin. Predicted to be active in nucleus.
Source: NCBI Gene 344022 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 49 total
- Transcription factor: yes — 15 downstream targets (CollecTRI)
- MANE Select transcript:
NM_001134462
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31839 |
| Approved symbol | NOTO |
| Name | notochord homeobox |
| Location | 2p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000214513 |
| Ensembl biotype | protein_coding |
| OMIM | 620695 |
| Entrez | 344022 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000398468
RefSeq mRNA: 1 — MANE Select: NM_001134462
NM_001134462
CCDS: CCDS46335
Canonical transcript exons
ENST00000398468 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001533249 | 73210771 | 73212513 |
| ENSE00001533251 | 73208400 | 73208614 |
| ENSE00001533254 | 73202574 | 73203048 |
Expression profiles
Bgee: expression breadth tissue_specific, 4 present calls, max score 48.77.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2564 / max 45.7923, expressed in 60 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 20941 | 0.2564 | 60 |
Top tissues by expression
116 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| stromal cell of endometrium | CL:0002255 | 48.77 | gold quality |
| duodenum | UBERON:0002114 | 43.13 | silver quality |
| colonic epithelium | UBERON:0000397 | 41.54 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 40.62 | silver quality |
| bone marrow | UBERON:0002371 | 38.64 | gold quality |
| bone marrow cell | CL:0002092 | 38.01 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 37.69 | gold quality |
| muscle tissue | UBERON:0002385 | 37.68 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.16 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| calcaneal tendon | UBERON:0003701 | 36.38 | gold quality |
| rectum | UBERON:0001052 | 35.74 | silver quality |
| right coronary artery | UBERON:0001625 | 35.44 | gold quality |
| sural nerve | UBERON:0015488 | 35.30 | gold quality |
| apex of heart | UBERON:0002098 | 35.17 | gold quality |
| leukocyte | CL:0000738 | 34.80 | gold quality |
| blood | UBERON:0000178 | 34.54 | gold quality |
| monocyte | CL:0000576 | 34.42 | gold quality |
| liver | UBERON:0002107 | 33.97 | gold quality |
| mucosa of stomach | UBERON:0001199 | 33.86 | gold quality |
| cerebellum | UBERON:0002037 | 33.54 | gold quality |
| uterine cervix | UBERON:0000002 | 33.44 | gold quality |
| cerebellar cortex | UBERON:0002129 | 33.37 | gold quality |
| stomach | UBERON:0000945 | 33.33 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 33.22 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 33.08 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 33.01 | gold quality |
| body of stomach | UBERON:0001161 | 32.57 | gold quality |
| endometrium | UBERON:0001295 | 32.36 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.63 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
15 targets.
| Target | Regulation |
|---|---|
| ADAM2 | |
| ALG3 | |
| BTK | |
| CAT | |
| CCR4 | |
| CD74 | |
| ENO2 | |
| EOMES | |
| LCK | |
| NOTO | |
| SUPT7L | |
| TOP2B | |
| TPM1 | |
| USP21 | |
| WT1 |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA0710.1 | NOTO | NK |
| MA0710.2 | NOTO | NK |
JASPAR matrix evidence (PMIDs): PMID:18585360
Upstream regulators (CollecTRI, top): AP1, NFKB, NOTO
miRNA regulators (miRDB)
10 targeting NOTO, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-8080 | 99.82 | 67.52 | 1342 |
| HSA-MIR-4316 | 99.37 | 65.75 | 1360 |
| HSA-MIR-10B-3P | 99.04 | 66.98 | 988 |
| HSA-MIR-554 | 95.20 | 66.98 | 341 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | noto | ENSDARG00000021201 |
| mus_musculus | Noto | ENSMUSG00000068302 |
| rattus_norvegicus | Noto | ENSRNOG00000037863 |
| drosophila_melanogaster | CG18599 | FBGN0038592 |
| caenorhabditis_elegans | ceh-5 | WBGENE00000430 |
Paralogs (1): GSX1 (ENSG00000169840)
Protein
Protein identifiers
Homeobox protein notochord — A8MTQ0 (reviewed: A8MTQ0)
All UniProt accessions (1): A8MTQ0
UniProt curated annotations — full annotation on UniProt →
Function. Transcription regulator acting downstream of both FOXA2 and Brachyury (T) during notochord development. Required for node morphogenesis. Is essential for cilia formation in the posterior notochord (PNC) and for left-right patterning; acts upstream of FOXJ1 and RFX3 in this process and is required for the expression of various components important for axonemal assembly and function. Plays a role in regulating axial versus paraxial cell fate. Activates the transcription of ciliary proteins C11orf97 homolog, FAM183B and SPACA9 in the embryonic ventral node.
Subcellular location. Nucleus.
RefSeq proteins (1): NP_001127934* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR050877 | EMX-VAX-Noto_Homeobox_TFs | Family |
Pfam: PF00046
UniProt features (9 total): compositionally biased region 3, region of interest 2, sequence variant 2, chain 1, DNA-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MTQ0-F1 | 68.69 | 0.26 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9796292 | Formation of axial mesoderm |
MSigDB gene sets: 54 (showing top):
GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, GOBP_EPITHELIUM_DEVELOPMENT, GOBP_NEUROGENESIS, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOBP_DORSAL_VENTRAL_PATTERN_FORMATION, GOBP_SPECIFICATION_OF_SYMMETRY, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, GOBP_EMBRYONIC_HEART_TUBE_DEVELOPMENT, GOBP_EMBRYONIC_ORGAN_MORPHOGENESIS, GOBP_HEART_MORPHOGENESIS, GOBP_EMBRYONIC_PATTERN_SPECIFICATION, GOBP_CILIUM_ORGANIZATION, GOBP_ORGANELLE_ASSEMBLY, GOBP_HEAD_DEVELOPMENT
GO Biological Process (11): heart looping (GO:0001947), regulation of transcription by RNA polymerase II (GO:0006357), central nervous system development (GO:0007417), brain development (GO:0007420), embryonic pattern specification (GO:0009880), dorsal/ventral pattern formation (GO:0009953), neuron differentiation (GO:0030182), notochord development (GO:0030903), motile cilium assembly (GO:0044458), regulation of cilium assembly (GO:1902017), determination of left/right symmetry (GO:0007368)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Gastrulation | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cilium assembly | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| embryonic heart tube morphogenesis | 1 |
| determination of heart left/right asymmetry | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| nervous system development | 1 |
| system development | 1 |
| central nervous system development | 1 |
| animal organ development | 1 |
| head development | 1 |
| pattern specification process | 1 |
| embryo development | 1 |
| regionalization | 1 |
| cell differentiation | 1 |
| generation of neurons | 1 |
| embryonic organ development | 1 |
| regulation of plasma membrane bounded cell projection assembly | 1 |
| regulation of organelle assembly | 1 |
| determination of bilateral symmetry | 1 |
| left/right pattern formation | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
502 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NOTO | PRAMEF18 | Q5VWM3 | 447 |
| NOTO | FOXA2 | Q9Y261 | 394 |
| NOTO | PRADC1 | Q9BSG0 | 370 |
| NOTO | HECTD3 | Q5T447 | 369 |
| NOTO | KLRG2 | A4D1S0 | 347 |
| NOTO | MCIDAS | D6RGH6 | 337 |
| NOTO | FOXJ1 | Q92949 | 336 |
| NOTO | TBX6 | O95947 | 325 |
| NOTO | CHRD | Q9H2X0 | 320 |
| NOTO | MRPL45 | Q9BRJ2 | 320 |
| NOTO | PALD1 | Q9ULE6 | 319 |
| NOTO | ACSM4 | P0C7M7 | 310 |
| NOTO | RFX3 | P48380 | 308 |
| NOTO | PTCD3 | Q96EY7 | 298 |
| NOTO | MRPL46 | Q9H2W6 | 298 |
IntAct
103 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NOTO | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | KRTAP19-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | FAM9B | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | TTC23 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | APOBEC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | NKX2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | KRTAP5-6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | LDLRAP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | IP6K3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | CHAF1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | LRP10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | BTF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | POU4F2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | CEP19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | FOXD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | KRT34 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | HNRNPK | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-3 | NOTO | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | ANKRD11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | MAGED1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | CCDC120 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | GLYCTK | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | BAG3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | FOXH1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | EIPR1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | MEIS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (35): NOTO (Two-hybrid), NOTO (Two-hybrid), NOTO (Two-hybrid), NOTO (Two-hybrid), NOTO (Two-hybrid), NOTO (Two-hybrid), NOTO (Two-hybrid), NOTO (Two-hybrid), NOTO (Two-hybrid), NOTO (Two-hybrid), NOTO (Two-hybrid), NOTO (Two-hybrid), NOTO (Two-hybrid), NOTO (Two-hybrid), NOTO (Two-hybrid)
ESM2 similar proteins: A1YEV8, A1YF08, A1YG25, A1YG85, A2RU54, A2T711, A2T756, A8MTQ0, O14813, O15522, O35160, O35602, O43763, O70218, P28360, P42580, P43687, P50223, P52945, P52946, P52947, P70118, P70354, P81062, Q06348, Q2VL79, Q2VL84, Q2VL85, Q2VL87, Q2VL88, Q61663, Q62066, Q62782, Q6XYB7, Q7YRX0, Q96IS3, Q99811, Q9DED6, Q9ER42, Q9GK08
Diamond homologs: A1A546, A1L2P5, A6NNA5, A6YP92, A8DT10, A8MTQ0, G5EC89, G5ECT8, O09113, O14813, O15266, O35085, O35137, O35690, O35750, O42115, O42201, O42370, O42567, O43365, O60902, O70137, O93353, O93590, O95076, O97039, P02831, P09027, P0DMV5, P18488, P20269, P23759, P23760, P24610, P31249, P31316, P31357, P47239, P50901, P56407
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 32 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 5 | 16.4× | 6e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
49 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 44 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
438 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:73208618:G:GT | donor_gain | 1.0000 |
| 2:73205735:GCT:G | donor_gain | 0.9900 |
| 2:73208398:AG:A | acceptor_gain | 0.9900 |
| 2:73208399:GG:G | acceptor_gain | 0.9900 |
| 2:73208562:TGGGG:T | donor_gain | 0.9900 |
| 2:73210764:A:G | acceptor_gain | 0.9900 |
| 2:73210765:TTATA:T | acceptor_loss | 0.9900 |
| 2:73210766:TATA:T | acceptor_loss | 0.9900 |
| 2:73210768:TA:T | acceptor_loss | 0.9900 |
| 2:73210770:G:GT | acceptor_loss | 0.9900 |
| 2:73210770:GGT:G | acceptor_gain | 0.9900 |
| 2:73210770:GGTGA:G | acceptor_gain | 0.9900 |
| 2:73208610:ACCAG:A | donor_loss | 0.9800 |
| 2:73208611:CCAG:C | donor_loss | 0.9800 |
| 2:73208612:CAGGT:C | donor_loss | 0.9800 |
| 2:73208613:AGGTG:A | donor_loss | 0.9800 |
| 2:73208614:GG:G | donor_loss | 0.9800 |
| 2:73208615:G:GA | donor_loss | 0.9800 |
| 2:73208616:T:A | donor_loss | 0.9800 |
| 2:73210769:A:AG | acceptor_gain | 0.9800 |
| 2:73210770:G:GG | acceptor_gain | 0.9800 |
| 2:73208618:G:T | donor_gain | 0.9700 |
| 2:73202977:GC:G | donor_gain | 0.9600 |
| 2:73208397:TAGGG:T | acceptor_loss | 0.9600 |
| 2:73208398:A:C | acceptor_loss | 0.9600 |
| 2:73208399:GGGTT:G | acceptor_gain | 0.9600 |
| 2:73210763:A:AG | acceptor_gain | 0.9600 |
| 2:73203626:GCTCT:G | donor_gain | 0.9500 |
| 2:73208398:A:AG | acceptor_gain | 0.9500 |
| 2:73208399:G:GG | acceptor_gain | 0.9500 |
AlphaMissense
1589 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:73208504:T:C | F163L | 0.999 |
| 2:73208506:T:A | F163L | 0.999 |
| 2:73208506:T:G | F163L | 0.999 |
| 2:73208540:T:C | F175L | 0.999 |
| 2:73208542:T:A | F175L | 0.999 |
| 2:73208542:T:G | F175L | 0.999 |
| 2:73210783:T:C | F204L | 0.999 |
| 2:73210785:C:A | F204L | 0.999 |
| 2:73210785:C:G | F204L | 0.999 |
| 2:73208529:T:C | L171S | 0.998 |
| 2:73210784:T:C | F204S | 0.997 |
| 2:73210789:A:G | N206D | 0.997 |
| 2:73208505:T:C | F163S | 0.996 |
| 2:73208505:T:G | F163C | 0.996 |
| 2:73210782:G:C | W203C | 0.996 |
| 2:73210782:G:T | W203C | 0.996 |
| 2:73210790:A:G | N206S | 0.996 |
| 2:73210793:G:C | R207P | 0.996 |
| 2:73208541:T:C | F175S | 0.995 |
| 2:73208541:T:G | F175C | 0.995 |
| 2:73210780:T:A | W203R | 0.995 |
| 2:73210780:T:C | W203R | 0.995 |
| 2:73210792:C:A | R207S | 0.995 |
| 2:73208601:T:C | L195P | 0.994 |
| 2:73210784:T:G | F204C | 0.994 |
| 2:73210790:A:C | N206T | 0.994 |
| 2:73210791:C:A | N206K | 0.994 |
| 2:73210791:C:G | N206K | 0.994 |
| 2:73210797:G:C | R208S | 0.994 |
| 2:73210797:G:T | R208S | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000285024 (2:73206984 G>A), RS1000387681 (2:73207398 G>C,T), RS1000713925 (2:73208203 C>T), RS1000902692 (2:73211799 A>G), RS1001286465 (2:73205475 G>A), RS1001926724 (2:73208605 A>T), RS1001938402 (2:73210781 G>A,T), RS1001979042 (2:73208972 G>A), RS1002101800 (2:73202275 G>C), RS1002263111 (2:73201908 CTCAAATCAAA>C,CTCAAATCAAATCAAA,CTCAAATCAAATCAAATCAAA), RS1002288778 (2:73204161 C>G,T), RS1002307386 (2:73210543 C>T), RS1002424612 (2:73204400 C>T), RS1002907415 (2:73209202 G>A), RS1002929802 (2:73210104 A>G)
Disease associations
OMIM: gene MIM:620695 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005316_336 | Intelligence (MTAG) | 2.000000e-10 |
| GCST006269_1111 | General cognitive ability | 4.000000e-10 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004337 | intelligence |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| nutlin 3 | affects cotreatment, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| Asbestos, Crocidolite | decreases methylation | 1 |
| Asbestos, Amosite | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.